BR112018001719A2 - composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. - Google Patents
composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica.Info
- Publication number
- BR112018001719A2 BR112018001719A2 BR112018001719A BR112018001719A BR112018001719A2 BR 112018001719 A2 BR112018001719 A2 BR 112018001719A2 BR 112018001719 A BR112018001719 A BR 112018001719A BR 112018001719 A BR112018001719 A BR 112018001719A BR 112018001719 A2 BR112018001719 A2 BR 112018001719A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- polymeric micelle
- preparing
- micelle
- polymeric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150106628A KR101787447B1 (ko) | 2015-07-28 | 2015-07-28 | 보관 안정성이 향상된 약학 조성물 및 그의 제조 방법 |
PCT/KR2016/008269 WO2017018819A1 (en) | 2015-07-28 | 2016-07-28 | Pharmaceutical composition with improved storage stability and method for preparing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018001719A2 true BR112018001719A2 (pt) | 2018-09-18 |
Family
ID=57884931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018001719A BR112018001719A2 (pt) | 2015-07-28 | 2016-07-28 | composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP3328436A4 (de) |
JP (1) | JP2018521106A (de) |
KR (1) | KR101787447B1 (de) |
CN (1) | CN106659680A (de) |
AU (1) | AU2016299547A1 (de) |
BR (1) | BR112018001719A2 (de) |
CA (1) | CA2993923A1 (de) |
HK (1) | HK1249440A1 (de) |
IL (1) | IL257181A (de) |
MX (1) | MX2018001222A (de) |
RU (1) | RU2018107054A (de) |
WO (1) | WO2017018819A1 (de) |
ZA (1) | ZA201801186B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20190231689A1 (en) * | 2018-01-29 | 2019-08-01 | Samyang Biopharmaceuticals Corporation | Amphiphilic Block Copolymer Composition With Enhanced Micelle Stability |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7550157B2 (en) * | 2000-05-12 | 2009-06-23 | Samyang Corporation | Method for the preparation of polymeric micelle via phase separation of block copolymer |
US7879317B2 (en) * | 2001-10-18 | 2011-02-01 | Samyang Corporation | Polymeric micelle compositions with improved stability and methods of making thereof |
ATE487134T1 (de) | 2007-03-06 | 2010-11-15 | Cell Therapeutics Europe Srl | Verfahren zur bestimmung der menge konjugierten taxans in polyglutaminsäure-taxan-konjugaten |
KR101024742B1 (ko) * | 2007-12-31 | 2011-03-24 | 주식회사 삼양사 | 탁산 함유 양친성 블록 공중합체 미셀 조성물 및 그 제조방법 |
CA2709967C (en) * | 2007-12-31 | 2012-05-29 | Samyang Corporation | Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof |
EP2201935B1 (de) * | 2008-12-26 | 2020-07-08 | Samyang Biopharmaceuticals Corporation | Polymere Mizellenzusammensetzung, die ein schlecht lösliches Arzneimittel enthält, und zugehöriges Herstellungsverfahren |
-
2015
- 2015-07-28 KR KR1020150106628A patent/KR101787447B1/ko active IP Right Grant
-
2016
- 2016-07-28 MX MX2018001222A patent/MX2018001222A/es unknown
- 2016-07-28 RU RU2018107054A patent/RU2018107054A/ru unknown
- 2016-07-28 JP JP2018504276A patent/JP2018521106A/ja active Pending
- 2016-07-28 CA CA2993923A patent/CA2993923A1/en not_active Abandoned
- 2016-07-28 EP EP16830852.6A patent/EP3328436A4/de not_active Withdrawn
- 2016-07-28 CN CN201680001944.8A patent/CN106659680A/zh active Pending
- 2016-07-28 WO PCT/KR2016/008269 patent/WO2017018819A1/en active Application Filing
- 2016-07-28 AU AU2016299547A patent/AU2016299547A1/en not_active Abandoned
- 2016-07-28 BR BR112018001719A patent/BR112018001719A2/pt not_active Application Discontinuation
-
2018
- 2018-01-28 IL IL257181A patent/IL257181A/en unknown
- 2018-02-21 ZA ZA2018/01186A patent/ZA201801186B/en unknown
- 2018-07-13 HK HK18109125.9A patent/HK1249440A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HK1249440A1 (zh) | 2018-11-02 |
EP3328436A4 (de) | 2019-03-20 |
RU2018107054A (ru) | 2019-08-28 |
EP3328436A1 (de) | 2018-06-06 |
KR20170014059A (ko) | 2017-02-08 |
JP2018521106A (ja) | 2018-08-02 |
WO2017018819A1 (en) | 2017-02-02 |
CA2993923A1 (en) | 2017-02-02 |
MX2018001222A (es) | 2018-04-24 |
IL257181A (en) | 2018-03-29 |
ZA201801186B (en) | 2018-12-19 |
CN106659680A (zh) | 2017-05-10 |
RU2018107054A3 (de) | 2019-08-28 |
KR101787447B1 (ko) | 2017-10-19 |
AU2016299547A1 (en) | 2018-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002772A1 (es) | Composiciones de insulina de rápida acción | |
SG10201803042PA (en) | Anti-tim-3 antibodies | |
EP3268435A4 (de) | Polymere bodipy-farbstoffe und verfahren zur verwendung davon | |
BR112018006696A2 (pt) | métodos e sistemas para obter óleo a partir de uma composição de vinhoto | |
BR112015032718A2 (pt) | composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos | |
BR112018002983A2 (pt) | composição compreendendo uma lactama e um álcool | |
BR112016017584A2 (pt) | Composições de nanotribologia e métodos relacionados incluindo nanofolhas moleculares | |
GEP201706760B (en) | Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same | |
EP3130355A4 (de) | Pharmazeutische zusammensetzung mit pregabalin mit verbesserter stabilität und verfahren zur herstellung davon | |
BR112016014880A2 (pt) | Composição farmacêutica incluindo palonosetron | |
EP3409709A4 (de) | Photohärtungsverfahren, verbindung und darin verwendete zusammensetzung | |
HRP20200104T8 (hr) | Novi heterociklični spoj, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto | |
CY1123408T1 (el) | Φαρμακευτικες συνθεσεις και χρηση των αυτων | |
EA201791716A1 (ru) | Фармацевтический состав | |
BR112016003019A2 (pt) | composto, composição farmacêutica, método para tratar câncer em um sujeito com necessidade do mesmo, e método para inibir uma desoxicitidina quinase | |
EP3252087A4 (de) | Zusammensetzung zur formung von leicht abzutrennenden dünnschichtfilmen sowie und leicht abzutrennende dünnschichtfilme | |
BR112018067656A2 (pt) | composições farmacêuticas anti-abuso | |
BR112018001725A2 (pt) | composição farmacêutica com micela polimérica. | |
EP3278790A4 (de) | Antioxidations- oder anti-aging-mittel mit 5-adamantan-1-yl-n-(2,4-dihydroxybenzyl)-2,4-dimethoxybenzamid | |
BR112018001736A2 (pt) | ?composição farmacêutica com micela polimérica? | |
BR112018001719A2 (pt) | composição farmacêutica com micela polimérica, e, método para preparação de uma composição farmacêutica com micela polimérica. | |
EP3330378A4 (de) | Modifizierte sirna und pharmazeutische zusammensetzung damit | |
EP3304051A4 (de) | Verbindungen zur markierung von aminhaltigen verbindungen und deren verwendung | |
FI20155976A (fi) | Menetelmä liima-ainekoostumuksen valmistamiseksi, liima-ainekoostumus ja sen käyttö | |
BR112018001737A2 (pt) | composição farmacêutica com micela polimérica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |